Cosmo Bio Company,Limited (3386.T)

JPY 1154.0

(0.17%)

Total Assets Summary of Cosmo Bio Company,Limited

  • Cosmo Bio Company,Limited's latest annual total assets in 2023 was 10.87 Billion JPY , up 5.42% from previous year.
  • Cosmo Bio Company,Limited's latest quarterly total assets in 2024 Q2 was 11.73 Billion JPY , up 1.25% from previous quarter.
  • Cosmo Bio Company,Limited reported annual total assets of 10.31 Billion JPY in 2022, up 2.39% from previous year.
  • Cosmo Bio Company,Limited reported annual total assets of 10.07 Billion JPY in 2021, up 4.48% from previous year.
  • Cosmo Bio Company,Limited reported quarterly total assets of 11.73 Billion JPY for 2024 Q2, up 1.25% from previous quarter.
  • Cosmo Bio Company,Limited reported quarterly total assets of 10.77 Billion JPY for 2023 Q3, down -0.73% from previous quarter.

Annual Total Assets Chart of Cosmo Bio Company,Limited (2023 - 2019)

Historical Annual Total Assets of Cosmo Bio Company,Limited (2023 - 2019)

Year Total Assets Total Assets Growth
2023 10.87 Billion JPY 5.42%
2022 10.31 Billion JPY 2.39%
2021 10.07 Billion JPY 4.48%
2020 9.64 Billion JPY 8.44%
2019 8.89 Billion JPY 0.0%

Peer Total Assets Comparison of Cosmo Bio Company,Limited

Name Total Assets Total Assets Difference
Shin Nippon Biomedical Laboratories, Ltd. 76.3 Billion JPY 85.751%
DNA Chip Research Inc. 982.47 Million JPY -1006.59%
H.U. Group Holdings, Inc. 295.35 Billion JPY 96.319%
FALCO HOLDINGS Co., Ltd. 36.42 Billion JPY 70.152%
BML, Inc. 170.99 Billion JPY 93.642%
Human Metabolome Technologies, Inc. 2.6 Billion JPY -317.608%
Precision System Science Co., Ltd. 6.39 Billion JPY -69.967%